FDA Approves Moderna’s RSV Vaccine For Older Adults
CIDRAP reports on the approval of Moderna's mRNA vaccine, called mRESVIA, which is expected to be available during the 2024-25 respiratory virus season. Other news is on a rise in whooping cough cases and the latest developments on the bird flu virus.